Sanofi
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · France · 10K+ Employees
View Company Info for Free
Overview
Headquarters
46 Avenue De La Grande Armee, Paris, Île...Phone Number
+33153774000Website
www.sanofi.comRevenue
$54.2 BillionStock Symbol
SNYIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
4
4
3
3
2
About Sanofi
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide to advance sustainable and responsible healthcare solutions.Explore more
Sanofi Org Chart
YN
Chief Financial Officer (South Korea, Austral...
WM
Chief Financial Officer (Egypt, Sudan)
MP
GSD Controller
AR
Gtn Cost Controller
RF
Industrial Controller
HL
Cost Controller
JB
Opex Vaccines Controller (Brazil)
JA
LATAM Supply Chain Finance Controller
OB
Financial Controller
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sanofi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Sanofi has new funding data
Check if Sanofi has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sanofi launches new products
Click to see if Sanofi had a recent Job posting/layoffs
Check out if Sanofi is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Sanofi recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Sanofi
Sanofi, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Sanofi
Find more new buyers
Company Profile Activity
Activity Insights
Sanofi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sanofi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sanofi.
Sanofi Tech Stack
A closer look at the technologies used by Sanofi
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Board of Directors, Corporate Strategy
Open Position
Open Position
Sanofi News & Media
Why the Amlitelimab Setback Isn’t Enough to Sink Sanofi’s Multi-Billion Dollar Engine
It was reported on July 24 that Sanofi (NASDAQ:SNY) shares underperformed in European trading following the company’s decision to drop the clinical development of its eczema candidate, amlitelimab, for moderate-to-severe atopic dermatitis. Rather than a fundamental breakdown, the move reflects an aggressive R&D pipeline review under CEO Belén Garijo, who chose to pull the plug […]Antipodes Exited Sanofi (SNY) After Repeated Pipeline Setbacks
Antipodes Partners published its “Antipodes Global Strategy” second-quarter 2026 investor letter, highlighting the key performance stocks, portfolio changes, and the market outlook. A copy of the letter can be downloaded here. The second quarter of 2026 delivered one of the strongest equity market recoveries in recent history, as global equities gained 14.9% in US dollar terms. Renewed […]National Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims
Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs' National Advertising Division found certain challenged claims made by Sanofi S.A. supported but recommended that Sanofi modify or discontinue other claims regarding long-lasting clearer skin, fast itch relief, and a prescriber-facing day-2 itch relief claim. Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs' National Advertising Division found certain challenged claims made by SPress Release: Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Sanofi’s MenQuadfi approved in the EU for use in infants from age six weeks against invasive meningococcal disease
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sanofi
Sign Up For FreeTo access detailed company insights
Sanofi is a global biopharmaceutical company dedicated to improving lives through scientific innovation. The company focuses on discovering, developing, and delivering medicines and vaccines across immunology, rare diseases, neurology, oncology, and preventive care. Guided by research and patient needs, it works with healthcare partners worldwide t... Read More
